Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(6 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content</big>
Line 16: Line 18:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 +
|-
 +
|
 +
==== CHAPTER 2 (PITUITARY TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
 
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
Line 258: Line 281:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 3 (THYROID TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
Line 534: Line 578:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
+
|
−
|Disease
+
==== CHAPTER 4 (PARATHYROID TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 588: Line 653:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 5 (ADRENAL GLAND TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[ENDO5:Adrenal_rests|Adrenal rests]]
 
|[[ENDO5:Adrenal_rests|Adrenal rests]]
Line 699: Line 785:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
+
|
−
|Disease
+
==== CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 786: Line 893:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
 
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
Line 908: Line 1,036:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
+
|
−
|Disease
+
==== CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 984: Line 1,133:
 
|
 
|
 
|
 
|
 +
|-
 +
|
 +
==== CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
 
|[[ENDO5:Lipoma|Lipoma]]
 
|[[ENDO5:Lipoma|Lipoma]]
Line 1,128: Line 1,298:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
+
|
−
|Disease
+
==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,205: Line 1,396:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 11 (GERM CELL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
+
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,227: Line 1,428:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
+
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,238: Line 1,439:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 12 (METASTASIS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
+
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,260: Line 1,471:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
+
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,271: Line 1,482:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
+
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,282: Line 1,493:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
−
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
+
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,304: Line 1,547:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
+
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,315: Line 1,558:
 
|
 
|
 
|-
 
|-
−
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
+
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,325: Line 1,568:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
 
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
 
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[ENDO5:Carney_complex|Carney complex]]
 
|[[ENDO5:Carney_complex|Carney complex]]
Line 1,372: Line 1,626:
 
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
 
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]
 
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]

Latest revision as of 14:08, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (PITUITARY TUMOURS)
Somatotroph PitNET/adenoma Disease
Mammosomatotroph PitNET/adenoma Disease
Lactotroph PitNET/adenoma Disease
Thyrotroph PitNET/adenoma Disease
Mature plurihormonal PIT1-lineage PitNET/adenoma Disease
Immature PIT1-lineage PitNET/adenoma Disease
Acidophil stem cell PitNET/adenoma Disease
Mixed somatotroph-lactotroph PitNET/adenoma Disease
Corticotroph PitNET/adenoma Disease
Gonadotroph PitNET/adenoma Disease
Null cell PitNET/adenoma Disease
Plurihormonal PitNET/adenomas Disease
Multiple synchronous PitNET/adenomas of distinct lineages Disease
Metastatic PitNET Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituitary blastoma Disease
Pituicytomas Disease
Gangliocytoma and mixed gangliocytoma-PitNET/adenoma Disease
Sellar neurocytoma Disease
Meningiomas Disease
Chordoma Disease

CHAPTER 3 (THYROID TUMOURS)
Thyroglossal duct cyst Disease
Other congenital thyroid abnormalities Disease
Thyroid follicular nodular disease Disease
Follicular thyroid adenoma Disease
Follicular thyroid adenoma with papillary architecture Disease
Oncocytic adenoma of the thyroid Disease
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features Disease
Thyroid tumours of uncertain malignant potential Disease
Hyalinizing trabecular tumour Disease
Follicular thyroid carcinoma Disease
Invasive encapsulated follicular variant of papillary thyroid carcinoma Disease
Papillary thyroid carcinoma Disease
Oncocytic carcinoma of the thyroid Disease
High-grade follicular cell-derived non-anaplastic thyroid carcinoma Disease
Anaplastic thyroid carcinoma Disease
Medullary thyroid carcinoma Disease
Mixed medullary and follicular cell-derived thyroid carcinomas Disease
Mucoepidermoid carcinoma Disease
Secretory carcinoma Disease
Sclerosing mucoepidermoid carcinoma with eosinophilia Disease
Cribriform morular thyroid carcinoma Disease
Thymoma Disease
Spindle epithelial tumour with thymus-like elements Disease
Intrathyroidal thymic carcinoma Disease
Thyroblastoma Disease

CHAPTER 4 (PARATHYROID TUMOURS)
Parathyroid hyperplasia Disease
Parathyroid adenoma Disease
Parathyroid lipoadenoma Disease
Atypical parathyroid tumour Disease
Parathyroid carcinoma Disease

CHAPTER 5 (ADRENAL GLAND TUMOURS)
Adrenal rests Disease
Adrenal cysts Disease
Adrenal myelolipoma Disease
Congenital adrenal hyperplasia Disease
Adrenocortical nodular disease Disease
Adrenal cortical adenoma Disease
Adrenal cortical carcinoma Disease
Adrenal sex cord stromal tumour Disease
Adenomatoid tumour Disease
Adrenal melanoma Disease

CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS)
Neuroblastoma Disease
Ganglioneuroblastoma, intermixed Disease
Ganglioneuroblastoma, nodular Disease
Ganglioneuroma Disease
Phaeochromocytoma Disease
Sympathetic paraganglioma Disease
Parasympathetic paraganglioma Disease
Composite phaeochromocytomas and paragangliomas Disease

CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS)
Non-functioning (non-syndromic) pancreatic neuroendocrine tumours Disease
Insulinoma Disease
Glucagonoma Disease
Somatostatinoma Disease
Gastrinoma Disease
VIPoma Disease
Serotonin-producing tumours with and without carcinoid syndrome Disease
Other pancreatic neuroendocrine tumours with ectopic hormone production Disease
Pancreatic neuroendocrine carcinoma Disease
Mixed ductal adenocarcinoma-neuroendocrine neoplasms Disease
Mixed acinar-neuroendocrine carcinoma Disease

CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS)
Neuroendocrine tumours Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Merkel cell carcinoma Disease
Mixed neuroendocrine-non-neuroendocrine neoplasms Disease
Composite gangliocytoma/neuroma and neuroendocrine tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS)
Lipoma Disease
Solitary fibrous tumour Disease
Benign vascular tumours Disease
PEComa Disease
Glomangioma and glomus tumour Disease
Angiosarcoma Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcomas Disease
Schwannoma Disease
Neurofibroma Disease
Granular cell tumour Disease
Malignant peripheral nerve sheath tumour Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
IgG4-related disease Disease
Extranodal marginal zone lymphoma Disease
Diffuse large B-cell lymphoma Disease
Langerhans cell histiocytosis Disease
Rosai-Dorfman disease Disease
Erdheim-Chester disease Disease
Follicular dendritic cell sarcoma Disease

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours in endocrine organs Disease
Teratomas with endocrine differentiation Disease

CHAPTER 12 (METASTASIS)
Metastasis to the pituitary gland Disease
Metastasis to the thyroid gland Disease
Metastasis to the adrenal gland Disease

CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS)
Multiple endocrine neoplasia type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Multiple endocrine neoplasia type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Multiple endocrine neoplasia type 4 Disease
Multiple endocrine neoplasia type 5 (MAX-related tumours) Disease
Hyperparathyroidism-jaw tumour syndrome Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
SDH-deficient tumour syndromes Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Carney complex Disease
McCune-Albright syndrome Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Glucagon cell hyperplasia and neoplasia Disease
MAFA-related familial insulinomatosis Disease
Syndromic familial follicular cell-derived thyroid tumours Disease
Non-syndromic familial follicular cell-derived thyroid tumours Disease
Retrieved from "https://ccga.io/index.php?title=ENDO5:Volunteer_Assignments_and_Opportunities&oldid=15423"